Tuesday, January 21, 2025 10:58:29 AM
We would have had approvals already had it not been for the covid scam. I look for those FDA participants to be looking for a job this week as they are the same corrupted officials who emails showed a hateful bias against CytoDyn's Nader, "leronlimab never". Funny, they are both has beens now. It's usually better to make friends even with those who seem opposed. Our current Dr. Jay has this talent.
The US has just dropped out of the WHO who (sounds like an owl hiding in the treetop) supported Dr, Falsi ...pardon the pun, pardoned the pun ??
Remember when !! https://www.poz.com/article/ccr5blocking-antibody-leads-longterm-hiv-suppression
These studies and trials fly in the face of the old FDA. Times have changed perhaps?? Someone knows sumpin is up.
I have full faith some asleep at the wheel will be shocked at what is to come. $$$CYDY$$$ 2025
ps. Meanwhile I am quite exasperated at the lack of pigeon shorts and flippers with wings clipped. So I guess I will buy on the rising market of late.
Pigeons and owls, birds of a feather flock together both chirping in the hospital window, "cheer up, cheer up. we haven't got long".
Dr. The Amazing Dr.Jay....for Jonathan?? A stapler could be what the doctor ordered.
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/10/2025 10:16:32 PM
- CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:40:20 PM
- CytoDyn Announces Resolution of Class Action Lawsuit • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 11/24/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 10:15:12 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/04/2025 10:15:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2025 10:15:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 01:38:18 PM
- CytoDyn Secures $30 Million Commitment from Yorkville Advisors • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2025 12:30:21 PM
- CytoDyn to Present at the LD Micro Main Event XIX Investor Conference • GlobeNewswire Inc. • 10/09/2025 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/30/2025 09:15:05 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
